| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441196 | European Journal of Cancer | 2016 | 12 Pages |
Abstract
BR is also an effective and safe regimen for untreated CLL patients, outside of controlled clinical trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Massimo Gentile, Katja Zirlik, Stefania Ciolli, Francesca R. Mauro, Nicola Di Renzo, Lucia Mastrullo, Francesco Angrilli, Stefano Molica, Giovanni Tripepi, Annamaria Giordano, Francesco Di Raimondo, Carmine Selleri, Marta Coscia, Maurizio Musso,